MedTrace Logo

Hypnotic Medications and Memory: Effect of Drug Exposure During the Night

NCT01159652 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2014-08-26

No results posted yet for this study

Summary

The purpose of this study is to determine the effect of two hypnotic medications, zolpidem extended release and zaleplon, on memory. It is expected that a hypnotic with shorter drug duration will allow greater memory consolidation than a hypnotic with longer drug duration.

Conditions

  • Sleep
  • Memory

Interventions

DRUG

zaleplon

10 mg

DRUG

zolpidem extended release

12.5 mg

DRUG

bedtime placebo

placebo

DRUG

middle of the night placebo

placebo

Sponsors & Collaborators

  • American Academy of Sleep Medicine

    collaborator OTHER

  • St. Luke's Hospital, Chesterfield, Missouri

    lead OTHER

Principal Investigators

  • Janine M Hall-Porter, PhD · St. Luke's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2011-05-31
Completion
2011-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01159652 on ClinicalTrials.gov